Amarin Corporation Email Format

Pharmaceutical ManufacturingUnited States201-500 Employees

Amarin Corporation is a United States-based pharmaceutical manufacturer focused on cardiovascular disease. It owns and supports a branded product with regulatory approvals across multiple jurisdictions, underpinned by clinical trial evidence of efficacy and safety. The company uses a mixed commercial model, with direct U.S. sales and international distribution through a network of established partners spanning more than 90 markets.

Its work aims to reduce the cardiovascular disease burden for patients and communities and to advance cardiovascular science globally. The business targets patients and health systems seeking treatments for cardiovascular conditions, leveraging its global reach within the pharmaceutical industry. In June 2026, a Supreme Court ruling addressed Amarin's patent dispute with Hikma Pharmaceuticals related to icosapent ethyl (Vascepa), resulting in the dismissal of Amarin's infringement claim.

Get verified Amarin Corporation emails free

Company overview Employee directory